ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1830

Single-Cell and Spatial Profiling Reveal Proinflammatory and Profibrotic Fibroblast-Macrophage Niches in Lupus Nephritis

Chirag Raparia1, Paul Hoover2, Nir Hacohen3, Arnon Arazi4 and Anne Davidson1, 1Feinstein Institutes for Medical Research, Manhasset, NY, 2Brigham and Women's Hospital, Boston, MA, 3Broad Institute of MIT Harvard, Cambridge, MA, 4Feinstein Institutes for Medical Research, Acton, MA

Meeting: ACR Convergence 2025

Keywords: Fibroblasts, Other, Lupus nephritis, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1830–1854) Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus nephritis (LN) is a severe complication of SLE that can progress to chronic kidney disease, renal fibrosis, and eventual renal failure. Fibroblasts activated by pro-inflammatory cytokines and damage signals adopt a heterogeneous pro-inflammatory or profibrotic phenotype, which contribute to pathological fibrosis; however, the fibroblast landscape in autoimmune kidney disease remains poorly understood. Here, using renal biopsies collected through the AMP-SLE, we define and localize fibroblast heterogeneity in LN through single-cell and spatial transcriptomics.

Methods: Single-cell RNA-sequencing was used to profile dissociated kidney biopsies collected from 156 LN patients and 30 controls. High-resolution clustering was performed to identify both tissue and immune cell subsets. 16,187 PDGFRB+ stromal cells were used for further subclustering. Covarying Neighborhood Analysis (CNA) was performed to identify statistically significant Pearson’s correlations between the frequencies of cell subsets and the ISN chronicity and activity indices. Spatial transcriptomics was performed using the 10x Genomics Xenium platform, with a gene panel customized to allow the identification of high-resolution myeloid populations.

Results: We identified fibroblasts, myofibroblasts, CNN1+ vascular smooth muscle cells/pericytes (VSMC/peri), mesangial cells and renal endothelial cells, with relative expansion of fibroblasts, myofibroblasts, and mesangial cells occurring during LN together with relative contraction of CNN1- VSMC/peri (Fig.1A, B). Fine clustering of myofibroblasts revealed two transcriptionally distinct myofibroblast-like populations with increased collagen scores compared to other fibroblast-like subsets: proinflammatory myofibroblasts (Myofib1) and profibrotic myofibroblasts (Myofib2). CNA revealed that both clusters of myofibroblasts and the VCSM/Peri1 subset were positively correlated with chronicity (Fig. 1C), but not with the activity index. Gene expression and pathway enrichment analyses highlighted MyoFib2 as a matrix-producing, contractile population, while MyoFib1 was enriched for immune signaling and complement pathways. PDGFRA+, ACTA2+ C7+ ITGA3- Myofib1 myofibroblasts were located preferentially in the interstitium adjacent to CSF1R+ resident macrophages, whereas PDGFRA, ACTA2+, ITGA3+ VCAN+ Myofib2 myofibroblasts were located in sclerotic areas of the glomeruli and fibrous crescents adjacent to GPNMB+ FABP5+ damage-associated infiltrating macrophages (Fig. 2A-C). Vascular mural cells also showed heterogeneity: VCSM/Peri1 was enriched for immune-related genes and expressed a detachment profile, whereas VCSM/Peri2–6 retained a contractile phenotype.

Conclusion: Our findings reveal the diversity of PDGFRB+ populations in LN kidneys and the presence of both proinflammatory and profibrotic myofibroblasts in various renal compartments associated with LN chronicity. Previously described LN associated resident and infiltrating macrophages co-localize with proinflammatory and profibrotic fibroblasts respectively creating unique renal niches that promote tissue damage.

Supporting image 1Figure 1: Fibroblast-like PDGFRB+ cell landscape in Lupus Nephritis. A. UMAP of 6 PDGFRB+ subsets, each containing unique subclusters from single-cell RNA-sequencing of stromal cells from 156 LN patients and 30 live donor controls. B. A bar graph of each subcluster as a percentage of total PDGRB+ stromal cells in LN patients (Blue) and controls (red), highlighting subclusters that increased in frequency during LN (Purple box; Fib1-3, Myofib 1-2) and subclusters that decreased (Green box; CNN1+ VSCM/Per1-2). C. Covarying Neighborhood Analysis (CNA) on LN patients projecting onto the PDGFRB+ stromal cells showing association with chronicity. Red indicates a significant positive clinical correlation with the cell subset, while blue indicates a significant negative correlation. The false detection rate is less than 0.1.

Supporting image 2Figure 2: Spatial transcriptomic representation of a glomerulus from a LN patient renal biopsy. A. An overview of the area of interest (Top) with damage-associated macrophage transcripts GPNMP, FABP5, and CSF1R are highlighted. Magnification of the boxed area (bottom) shows GPNMP+ and FABP5+ macrophages localizing in the glomeruli and peri-glomeruli areas (white arrows) compared to macrophages expressing CSF1R alone in the interstitium B. Image of the same area (Top) with Myofib2 transcripts ACTA2, ITGA3, and VCAN highlighted. Magnification of the boxed area (bottom) shows Myofib2, located in the glomerulus and in the crescent (C) (white arrows). V indicates an Acta2+ blood vessel. C. Image of the same area (Top) with Myofib1 transcripts PDFGRA and C7 highlighted. Magnification of the boxed area (bottom) details Myofib1, which are predominantly located in the interstitium (white arrows), separate from Myofib2.


Disclosures: C. Raparia: None; P. Hoover: None; N. Hacohen: Calico Biosciences, 5, Cytoreason, 1, 11, Danger Bio, 1, 11, Moderna, 5, Repertoire Immune Medicines, 1, 11, Takeda, 5; A. Arazi: None; A. Davidson: None.

To cite this abstract in AMA style:

Raparia C, Hoover P, Hacohen N, Arazi A, Davidson A. Single-Cell and Spatial Profiling Reveal Proinflammatory and Profibrotic Fibroblast-Macrophage Niches in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/single-cell-and-spatial-profiling-reveal-proinflammatory-and-profibrotic-fibroblast-macrophage-niches-in-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-and-spatial-profiling-reveal-proinflammatory-and-profibrotic-fibroblast-macrophage-niches-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology